Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MMP1 | P03956 | 3/20 | 0.49 |
| ▸ | MMP2 | P08253 | 3/20 | 0.49 |
| ▸ | MMP9 | P14780 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20981664 | 0.88 | L3MBTL1 (0.82) | L3MBTL1NPC1RAB9AMAPTCYP1A2 | |
| SCHEMBL29659984 | 0.81 | L3MBTL1 (0.67) | L3MBTL1KMT2ANPC1RAB9AMEN1 | |
| SCHEMBL5546915 | 0.81 | L3MBTL1 (0.67) | L3MBTL1KMT2ANPC1RAB9AMEN1 | |
| SCHEMBL1131584 | 0.81 | NPSR1 (0.67) | L3MBTL1KMT2ANPC1RAB9AMEN1 | |
| SCHEMBL11871933 | 0.81 | ALDH1A1 (0.59) | KMT2ANPC1RAB9AMEN1MAPT | |
| SCHEMBL2883710 | 0.80 | MAPT (0.68) | L3MBTL1KMT2ARAB9AMEN1MAPT | |
| SCHEMBL21133073 | 0.80 | L3MBTL1 (0.65) | L3MBTL1KMT2ANPC1RAB9AMEN1 | |
| SCHEMBL1820057 | 0.80 | L3MBTL1 (0.65) | L3MBTL1NPC1RAB9AMAPTCYP1A2 | |
| SCHEMBL5545392 | 0.80 | L3MBTL1 (0.65) | L3MBTL1KMT2ANPC1RAB9AMEN1 | |
| SCHEMBL2723870 | 0.80 | L3MBTL1 (0.65) | L3MBTL1NPC1RAB9AMAPTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116102537-A | Quinolinone derivative and preparation method and application thereof | 四川大学 | 2023-05-12 | — | — | CN | disclosed |
| US-10808127-B2 | Color conversion with solid matrix films and green rhodamines | MOLECULED LTD. (IL) | 2020-10-20 | — | — | US | disclosed |
| US-10465110-B2 | Rhodamine based salts | StoreDot Ltd. (IL) | 2019-11-05 | — | — | US | disclosed |
| US-10227492-B2 | Modifications of the sol-gel films and production processes thereof | StoreDot Ltd. (IL) | 2019-03-12 | — | — | US | disclosed |
| US-20180105696-A1 | COLOR CONVERSION WITH SOLID MATRIX FILMS AND GREEN RHODAMINES | StoreDot Ltd. (IL) | 2018-04-19 | — | — | US | disclosed |
| US-20180072892-A1 | MODIFICATIONS OF THE SOL-GEL AND PROCESS THEREOF | StoreDot Ltd. (IL) | 2018-03-15 | — | — | US | disclosed |
| US-20180037738-A1 | COLOR CONVERSION WITH SOLID MATRIX FILMS | StoreDot Ltd. (IL) | 2018-02-08 | — | — | US | disclosed |
| US-20180039131-A1 | CONTROL OF ILLUMINATION SPECTRA FOR LCD DISPLAYS | StoreDot Ltd. (IL) | 2018-02-08 | — | — | US | disclosed |
| EP-3210966-A1 | ALKOXYPHENYLPROPYLAMINES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Acucela, Inc. (US) | 2017-08-30 | — | — | EP | disclosed |
| US-8497274-B2 | Heterocyclic compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-07-30 | — | — | US | disclosed |
| US-20120214855-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-08-23 | — | — | US | disclosed |
| US-8143258-B2 | Benzothiazole compounds useful for Raf inhibition | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-03-27 | — | — | US | disclosed |
| EP-2358689-A1 | Benzothiazole derivatives as anticancer agents | Takeda Pharmaceutical Company Limited (JP) | 2011-08-24 | — | — | EP | disclosed |
| US-20100216810-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-08-26 | — | — | US | disclosed |
| WO-2010064722-A1 | BENZOTHIAZOLE DERIVATIVES AS ANTICANCER AGENTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-06-10 | — | — | WO | disclosed |
| US-6764829-B2 | DETECTING PARASITES USING CHROMOGENIC SUBSTRATES; OBTAIN SAMPLE, INCUBATE WITH CHROMGENIC SUBSTRATE, DETECT FORMATION OF CHROMOPHORE PRODUCT | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY | 2004-07-20 | — | — | US | disclosed |
| US-20020132263-A1 | Enzyme detection/assay method and substrates | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2002-09-19 | — | — | US | disclosed |
| US-6379911-B2 | ANALYZING NUCLEOSIDE HYDROLASES; DETECTING PARASITES | ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY | 2002-04-30 | — | — | US | disclosed |
| US-20010019823-A1 | ENZYME DETECTION/ASSAY METHOD AND SUBSTRATES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2001-09-06 | — | — | US | disclosed |
| WO-1997031008-A1 | ENZYME DETECTION/ASSAY METHOD AND SUBSTRATES | INDUSTRIAL RESEARCH LIMITED (NZ) | 1997-08-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010019823-A1 | ENZYME DETECTION/ASSAY METHOD AND SUBSTRATES | PNP, TREH, XDH | L3MBTL1 2218/4885KMT2A 4064/4885NPC1 3012/4885 |
| US-20120214855-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | BRAF, NRAS, RAF1 | L3MBTL1 3413/4885KMT2A 1093/4885NPC1 4128/4885 |
| US-20100216810-A1 | HETEROCYCLIC COMPOUND AND USE THEREOF | BRAF, NRAS, RAF1 | L3MBTL1 3413/4885KMT2A 1093/4885NPC1 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.